Trial Profile
A study of Tolvaptan in cirrhotic patients with refractory ascites
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 10 May 2016 New trial record
- 17 Apr 2016 Preliminary results (n=17) presented at The International Liver Congress™ 2016